Meet The Team
Who’s Who
Rory McGoldrick
Co-Founder & Director
Rory took the leap of faith and founded Inspira Pharmaceuticals in 2020 to see if a virtual biotech start-up really could find a cure for deadly respiratory diseases. Eager and curious, Rory proves that no mission is too big to attempt. Rory boasts nearly two decades of experience in corporate finance and company start-ups. Passionate about innovation, Rory has managed to recruit an excellent team of partners and win the attention of high-quality investors. Rory has an LLB in Law from the University of Western Australia.
Nick Woolf
Co-Founder & Director
Nick is an accomplished leader and executive in life sciences with over 25 years of experience in industry, equity research and investment banking. Nick has held several senior industry roles, including CEO of AusCann Group (ASX:AC8) and senior roles with SUDA Pharmaceuticals (ASX:SUD); Phylogica (ASX:PYC); and Oxford BioMedica (LSE:OXB). He began his career as a healthcare investment banker and was formerly head of European biotech equity research at ABN Amro.
Nick has a BA (Hons) and MA in Chemistry from Oxford University.
Dr Neil Rzechorzek
Scientific Advisor
Neil is a skilled protein scientist with a background in biochemistry, biophysics and structural biology. With nearly 20 years of hands-on expertise, Neil advises on the key experiments that drive our technology forward. He has extensive experience in biotech consultancy and entrepreneurship, and holds a PhD from the Institute of Cancer Research (University of London, UK).
Dr Jess Jackson
Non-Executive Director
Dr Jackson is a biomedical scientist with drug development experience from preclinical research to post-marketing studies. She has significant experience working with Inspira’s core technology through a previous role with Inspira’s licensor. Jess provides a critical technical voice to assist Inspira to execute its ambitious R&D plan.